{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:35:13Z","timestamp":1789022113651,"version":"build-2803163510"},"reference-count":49,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015274","name":"Mexican Health Ministry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Mexican National Council of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005617","name":"BHF Centre of Research Excellence, Oxford","doi-asserted-by":"publisher","award":["RE\/13\/1\/30181"],"award-info":[{"award-number":["RE\/13\/1\/30181"]}],"id":[{"id":"10.13039\/501100005617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Chronic kidney disease (CKD) and diabetes are associated with dyslipidemia, metabolic abnormalities, and atherosclerotic risk. Nuclear magnetic resonance (NMR) spectroscopy provides much more detail on lipoproteins than traditional assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In about 38 000 participants from the Mexico City Prospective Study, aged 35 to 84 years and not using lipid-lowering medication, NMR spectroscopy quantified plasma concentrations of lipoprotein particles, their lipidic compositions, and other metabolic measures. Linear regression related low estimated glomerular filtration rate (eGFR; &amp;lt;60 mL\/min\/1.73 m2) to each NMR measure after adjustment for confounders and for multiplicity. Analyses were done separately for those with and without diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 38 081 participants (mean age 52 years, 64% women), low eGFR was present for 4.8% (306\/6403) of those with diabetes and 1.2% (365\/31 678) of those without diabetes. Among both those with and without diabetes, low eGFR was significantly associated with higher levels of 58 NMR measures, including apolipoprotein B (Apo-B), the particle numbers of most Apo-B containing lipoproteins, the cholesterol and triglycerides carried in these lipoproteins, several fatty acids, total cholines and phosphatidylcholine, citrate, glutamine, phenylalanine, \u03b2-OH-butyrate, and the inflammatory measure glycoprotein-A, and significantly lower levels of 13 NMR measures, including medium and small high-density lipoprotein particle measures, very low-density lipoprotein particle size, the ratio of saturated:total fatty acids, valine, tyrosine, and aceto-acetate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this Mexican population with high levels of adiposity and diabetes, low kidney function was associated with widespread alterations in lipidic and metabolic profiles, both in those with and without diabetes. These alterations may help explain the higher atherosclerotic risk experienced by people with CKD.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgab497","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T15:54:31Z","timestamp":1625327671000},"page":"2828-2839","source":"Crossref","is-referenced-by-count":15,"title":["Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-3768","authenticated-orcid":false,"given":"Diego","family":"Aguilar-Ramirez","sequence":"first","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-3871","authenticated-orcid":false,"given":"Jesus","family":"Alegre-D\u00edaz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-8243","authenticated-orcid":false,"given":"William G","family":"Herrington","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"},{"name":"MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4482-4418","authenticated-orcid":false,"given":"Natalie","family":"Staplin","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"},{"name":"MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9763-324X","authenticated-orcid":false,"given":"Ra\u00fal","family":"Ramirez-Reyes","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-2220","authenticated-orcid":false,"given":"Louisa","family":"Gnatiuc","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-6105","authenticated-orcid":false,"given":"Michael","family":"Hill","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"},{"name":"MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-5488","authenticated-orcid":false,"given":"Frederik","family":"Romer","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-7035","authenticated-orcid":false,"given":"Jason","family":"Torres","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-5905","authenticated-orcid":false,"given":"Eirini","family":"Trichia","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-6322","authenticated-orcid":false,"given":"Rachel","family":"Wade","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"},{"name":"MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-8602","authenticated-orcid":false,"given":"Rory","family":"Collins","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-9422","authenticated-orcid":false,"given":"Jonathan R","family":"Emberson","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"},{"name":"MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0704-9507","authenticated-orcid":false,"given":"Pablo","family":"Kuri-Morales","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-2904","authenticated-orcid":false,"given":"Roberto","family":"Tapia-Conyer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"issue":"9456","key":"2021110612095669400_CIT0001","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"Meguid El Nahas","year":"2005","journal-title":"Lancet."},{"key":"2021110612095669400_CIT0002","volume-title":"Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Global Burden of End-stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions.","author":"Bello","year":"2019"},{"issue":"10225","key":"2021110612095669400_CIT0003","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet."},{"issue":"9731","key":"2021110612095669400_CIT0004","article-title":"Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet."},{"issue":"7","key":"2021110612095669400_CIT0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"2021110612095669400_CIT0006","doi-asserted-by":"crossref","first-page":"e25920","DOI":"10.1371\/journal.pone.0025920","article-title":"Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis","volume":"6","author":"Mafham","year":"2011","journal-title":"PloS One."},{"issue":"9844","key":"2021110612095669400_CIT0007","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet."},{"key":"2021110612095669400_CIT0008","volume-title":"2019 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States.","year":"2019"},{"issue":"9854","key":"2021110612095669400_CIT0009","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet."},{"issue":"2","key":"2021110612095669400_CIT0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13300-016-0167-x","article-title":"Diabetes dyslipidemia","volume":"7","author":"Schofield","year":"2016","journal-title":"Diabetes Ther."},{"issue":"3","key":"2021110612095669400_CIT0011","first-page":"150","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab."},{"issue":"10","key":"2021110612095669400_CIT0012","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"2021110612095669400_CIT0013","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2006091006","article-title":"Lipoprotein metabolism and lipid management in chronic kidney disease","volume":"18","author":"Kwan","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"2021110612095669400_CIT0014","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14728222.2017.1369961","article-title":"New perspectives on CKD-induced dyslipidemia","volume":"21","author":"Berm\u00fadez-L\u00f3pez","year":"2017","journal-title":"Expert Opin Ther Targets."},{"issue":"9784","key":"2021110612095669400_CIT0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet."},{"issue":"1","key":"2021110612095669400_CIT0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.07320619","article-title":"Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD","volume":"15","author":"Lamprea-Montealegre","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"2021110612095669400_CIT0017","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOL.0000000000000318","article-title":"Diabetic dyslipidaemia","volume":"27","author":"Soran","year":"2016","journal-title":"Curr Opin Lipidol."},{"issue":"7","key":"2021110612095669400_CIT0018","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1681\/ASN.V1271516","article-title":"Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study","volume":"12","author":"Stack","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"2021110612095669400_CIT0019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int."},{"issue":"6","key":"2021110612095669400_CIT0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"2021110612095669400_CIT0021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circ Cardiovasc Genet."},{"issue":"3","key":"2021110612095669400_CIT0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.1073","article-title":"Genome-wide association study identifies multiple loci influencing human serum metabolite levels","volume":"44","author":"Kettunen","year":"2012","journal-title":"Nat Genet."},{"issue":"9","key":"2021110612095669400_CIT0023","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts","volume":"131","author":"W\u00fcrtz","year":"2015","journal-title":"Circulation."},{"issue":"1","key":"2021110612095669400_CIT0024","doi-asserted-by":"crossref","first-page":"15249","DOI":"10.1038\/s41598-018-33507-7","article-title":"Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations","volume":"8","author":"Barrios","year":"2018","journal-title":"Sci Rep."},{"issue":"7","key":"2021110612095669400_CIT0025","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1210\/clinem\/dgaa173","article-title":"Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes","volume":"105","author":"Tofte","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"20","key":"2021110612095669400_CIT0026","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa1605368","article-title":"Diabetes and cause-specific mortality in Mexico City","volume":"375","author":"Alegre-D\u00edaz","year":"2016","journal-title":"N Engl J Med."},{"issue":"6","key":"2021110612095669400_CIT0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-8587(18)30050-0","article-title":"Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study","volume":"6","author":"Herrington","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2021110612095669400_CIT0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ije\/dyl042","article-title":"Cohort profile: the Mexico City prospective study","volume":"35","author":"Tapia-Conyer","year":"2006","journal-title":"Int J Epidemiol."},{"key":"2021110612095669400_CIT0029","doi-asserted-by":"crossref","first-page":"113695","DOI":"10.1016\/j.ab.2020.113695","article-title":"Very long-term stability of lipid biomarkers in human serum","volume":"597","author":"Muzakova","year":"2020","journal-title":"Anal Biochem."},{"issue":"9","key":"2021110612095669400_CIT0030","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/clinchem\/48.9.1627","article-title":"Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies","volume":"48","author":"Youngman","year":"2002","journal-title":"Clin Chem."},{"key":"2021110612095669400_CIT0031","author":"International Federation of Clinical Chemistry"},{"issue":"4","key":"2021110612095669400_CIT0032","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem."},{"issue":"9","key":"2021110612095669400_CIT0033","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"5","key":"2021110612095669400_CIT0034","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ki.2010.462","article-title":"Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities","volume":"79","author":"Stevens","year":"2011","journal-title":"Kidney Int."},{"issue":"5","key":"2021110612095669400_CIT0035","first-page":"591","article-title":"Performance of MDRD-IDMS and CKD-EPI equations in Mexican individuals with normal renal function","volume":"34","author":"Arreola-Guerra","year":"2014","journal-title":"Nefrologia."},{"key":"2021110612095669400_CIT0036"},{"issue":"1","key":"2021110612095669400_CIT0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Se B"},{"key":"2021110612095669400_CIT0038","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an R package for Circos 2D track plots","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Bioinformatics."},{"issue":"1","key":"2021110612095669400_CIT0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5551\/jat.30015","article-title":"High-density lipoprotein subfractions and their oxidized subfraction particles in patients with chronic kidney disease","volume":"23","author":"Honda","year":"2016","journal-title":"J Atheroscler Thromb."},{"issue":"12","key":"2021110612095669400_CIT0040","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1161\/01.ATV.0000188555.60475.c2","article-title":"Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis","volume":"25","author":"Ikewaki","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"13","key":"2021110612095669400_CIT0041","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"HPS3\/TIMI55\u2013REVEAL Collaborative Group","year":"2017","journal-title":"N Engl J Med."},{"issue":"20","key":"2021110612095669400_CIT0042","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N Engl J Med."},{"issue":"22","key":"2021110612095669400_CIT0043","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med."},{"issue":"3","key":"2021110612095669400_CIT0044","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"HPS2-THRIVE Collaborative Group","year":"2014","journal-title":"N Engl J Med."},{"issue":"9","key":"2021110612095669400_CIT0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J."},{"key":"2021110612095669400_CIT0046","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.atherosclerosis.2020.02.002","article-title":"Apolipoprotein A-I concentrations and risk of coronary artery disease: a Mendelian randomization study","volume":"299","author":"Karjalainen","year":"2020","journal-title":"Atherosclerosis."},{"issue":"12","key":"2021110612095669400_CIT0047","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc17-1642","article-title":"Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation","volume":"40","author":"Wang","year":"2017","journal-title":"Diabetes Care."},{"issue":"5","key":"2021110612095669400_CIT0048","doi-asserted-by":"crossref","first-page":"e001221","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J Am Heart Assoc."},{"issue":"12","key":"2021110612095669400_CIT0049","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab497\/39619831\/dgab497.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/2828\/41098101\/dgab497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/2828\/41098101\/dgab497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T07:58:12Z","timestamp":1725350292000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/10\/2828\/6314282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,3]]},"published-print":{"date-parts":[[2021,9,27]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab497","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,7,3]]}}}